Krishna Institute Of Medical Science (KIMS) (NSE: KIMS) and Global Health Ltd (Medanta) (NSE: MEDANTA) are both listed in the Hospitals and Healthcare Centers industry. Krishna Institute Of Medical Science has a market capitalisation of ₹28,846 Cr and Global Health ₹34,910 Cr, as of 9 Nov 2026. Their P/E ratios are 119.6 and 62.8 respectively. Return on equity is 9.72% for Krishna Institute Of Medical Science and 15.03% for Global Health. Over one year, Krishna Institute Of Medical Science's share price is down 0.5% and Global Health's is up 12.1%.
| Metric | Krishna Institute Of Medical Science | Global Health |
|---|---|---|
| NSE Symbol | KIMS | MEDANTA |
| BSE Code | 543308 | 543654 |
| Share Price | ₹723.05 | ₹1,429.30 |
| Market Cap | ₹28,846 Cr | ₹34,910 Cr |
| P/E Ratio | 119.6 | 62.8 |
| Return on Equity | 9.72% | 15.03% |
| Return on Assets | 4.83% | 8.22% |
| Dividend Yield | — | 0.04% |
| Beta (1Y) | 0.66 | 0.31 |
| 1-Year Price Change | -0.5% | +12.1% |
| 3-Month Price Change | -11.8% | -3.2% |
| 52-Week Range | ₹575.80 – ₹858.00 | ₹956.00 – ₹1,544.00 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹1,344 Cr | ₹1,469 Cr |
| Quarterly Net Profit | ₹75 Cr | ₹219 Cr |
| Net Margin | 5.5% | 14.9% |
| EPS (Basic, Quarter) | ₹1.79 | ₹8.21 |
| Results Basis | consolidated | consolidated |
| Headquarters | Secunderabad, Telangana | Gurugram, Haryana |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers neurology, neurosurgery, psychiatry, and neuro rehabilitation; cardiology, cardiac and vascular surgery, heart transplant, and cardio rehabilitation; and pulmonology, interventional pulmonology, thoracic surgery, and lung transplant. It also provides medical and surgical gastroenterology, hepatobiliary pancreatic surgery, liver transplant, and bariatric surgery; ear, nose, throat, and head and neck surgery; and nephrology, urology, andrology, renal…
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology an…
Global Health has a market capitalisation of ₹34,910 Cr, against ₹28,846 Cr for Krishna Institute Of Medical Science as of 9 Nov 2026, about 1.2 times the size by market cap.
Krishna Institute Of Medical Science has a P/E of 119.6 and Global Health a P/E of 62.8 as of 9 Nov 2026.
Krishna Institute Of Medical Science has a return on equity of 9.72% and Global Health 15.03%.
Krishna Institute Of Medical Science's share price is down 0.5% over one year and Global Health's is up 12.1%.
Krishna Institute Of Medical Science reported revenue of ₹1,344 Cr and net profit of ₹75 Cr for Q2 FY27. Global Health reported revenue of ₹1,469 Cr and net profit of ₹219 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.